false0001336920
0001336920
2020-03-03
2020-03-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 3, 2020
|
| | |
| LEIDOS HOLDINGS, INC. | |
(Exact name of registrant as specified in its charter) | |
|
| | | | | | | |
Delaware | | 001-33072 | | 20-3562868 |
(State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | | | | | | |
11951 Freedom Drive | Reston | Virginia | | | | 20190 |
(Address of principal executive office) | | | | (Zip Code) |
| | | | | | | |
(571) 526-6000
(Registrants' telephone number, including area code)
Not Applicable
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
| |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
| |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
| |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
| |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: |
| | | | |
Title of each class | | Trading symbol(s) | | Name of each exchange on which registered |
Common stock, par value $.0001 per share | | LDOS | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On March 3, 2020, Jonathan W. Scholl, Health Group President for Leidos Holdings, Inc. (the “Company”), informed the Company of his intention to resign his employment with the Company, effective as of March 27, 2020, to pursue community and religious mission service.
(e) The Human Resources and Compensation Committee of the Company’s Board of Directors has approved a one-time cash separation payment of $1,500,000 to be paid to Mr. Scholl upon his separation of service with the Company, subject to a customary release of claims.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
| |
Exhibit Number | Description |
Exhibit 104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | | | | |
|
| | | | | | |
| | | | | | |
Dated: March 4, 2020 | | | | LEIDOS HOLDINGS, INC. |
| | | |
| | | | By: | | /s/ Raymond L. Veldman |
| | | | | | Raymond L. Veldman |
| | | | | | Senior Vice President and Deputy General Counsel |